KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Depreciation & Amortization (CF) (2016 - 2025)

Abbott Laboratories (ABT) has disclosed Depreciation & Amortization (CF) for 17 consecutive years, with $370.0 million as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) rose 8.19% to $370.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 billion through Dec 2025, up 7.01% year-over-year, with the annual reading at $1.4 billion for FY2025, 7.01% up from the prior year.
  • Depreciation & Amortization (CF) hit $370.0 million in Q4 2025 for Abbott Laboratories, roughly flat from $371.0 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $425.0 million in Q1 2021 to a low of $302.0 million in Q2 2023.
  • Historically, Depreciation & Amortization (CF) has averaged $339.8 million across 5 years, with a median of $332.5 million in 2023.
  • Biggest five-year swings in Depreciation & Amortization (CF): surged 59.18% in 2021 and later decreased 26.82% in 2022.
  • Year by year, Depreciation & Amortization (CF) stood at $369.0 million in 2021, then decreased by 15.72% to $311.0 million in 2022, then grew by 6.75% to $332.0 million in 2023, then increased by 3.01% to $342.0 million in 2024, then grew by 8.19% to $370.0 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for ABT at $370.0 million in Q4 2025, $371.0 million in Q3 2025, and $357.0 million in Q2 2025.